News Image

Top movers in Monday's pre-market session

By Mill Chart

Last update: May 6, 2024

Wondering what's happening in Monday's pre-market session? Find an overview in this article.

Today's pre-market losers

TickerChangeComment
GLYC-77.6%Despite yesterday's decline, GLYCOMIMETICS INC (NASDAQ:GLYC) experienced a further 77.6% decrease in share price during Monday's pre-market session, reaching $0.41. A press release (GlycoMimetics Announces Results of Pivotal Phase 3 Study of Uproleselan in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)) was released earlier today.
AFIB-36.49%ACUTUS MEDICAL INC's (NASDAQ:AFIB) stock price decreased by 36.49% to $0.09. Shareholders saw the stock price going 76.28% lower is the past 6 months.
MMAT-29.5%Despite yesterday's decline, META MATERIALS INC (NASDAQ:MMAT) experienced a further 29.5% decrease in share price during Monday's pre-market session, reaching $2.36. The stock is trading 68.49% lower than 6 months ago.
EYPT-29.08%Today's pre-market session reveals a 29.08% decline in the stock price of EYEPOINT PHARMACEUTICALS INC (NASDAQ:EYPT), now priced at $14.0. In the last 3 months the share price dropped with 31.22%.
SGBX-28.16%SAFE & GREEN HOLDINGS CORP's (NASDAQ:SGBX) shares fell 28.16% to $3.98 during Monday's pre-market session. Following yesterday's gain of 89.08%, NASDAQ:SGBX experiences a 28.16% decrease in today's pre-market session, indicating a pullback from the previous session's performance. Earlier today the company had a press release: Safe & Green Holdings Corp Announces Pricing of $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules.
LPTV-17.44%During Monday's pre-market session, the shares of LOOP MEDIA INC (NYSEARCA:LPTV) declined by 17.44%, reaching $0.26. In the last 3 months the stock lost 52.75%.
MPW-14.58%The stock price of MEDICAL PROPERTIES TRUST INC (NYSE:MPW) is declining by 14.58%, reaching $4.16 during Monday's pre-market session. Shareholders saw the stock price going 20.25% higher in the past month.
OCUL-13.29%OCULAR THERAPEUTIX INC's (NASDAQ:OCUL) stock price recorded a 13.29% decrease, falling to $5.35. NASDAQ:OCUL is releasing earnings today. Shareholders saw the stock price going 26.9% lower in the past month.
VAXX-13.18%Monday's pre-market session showed a 13.18% decrease in the stock price of VAXXINITY INC-A (NASDAQ:VAXX), reaching $0.12. Yesterday's significant 35.41% gain in NASDAQ:VAXX is met with a 13.18% decline in today's pre-market session, reflecting a shift in market sentiment. VAXXINITY INC-A is releasing earnings today.
POAI-12.71%Despite yesterday's decline, PREDICTIVE ONCOLOGY INC (NASDAQ:POAI) experienced a further 12.71% decrease in share price during Monday's pre-market session, reaching $1.58. In the last 3 months the stock lost 41.23%.

For the full premarket loser list go to our premarket losers page.

Back

EYEPOINT PHARMACEUTICALS INC

NASDAQ:EYPT (5/17/2024, 7:00:02 PM)

After market: 11.84 0 (0%)

11.84

-0.68 (-5.43%)

EYPT News

News Image3 days ago - EyePoint Pharmaceuticals, Inc.EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

WATERTOWN, Mass., May 16, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing...

News Image11 days ago - InvestorPlaceEYPT Stock Earnings: EyePoint Pharmaceuticals Misses EPS, Beats Revenue for Q1 2024

EYPT stock results show that EyePoint Pharmaceuticals missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

News Image11 days ago - BusinessInsiderEYPT Stock Earnings: EyePoint Pharmaceuticals Misses EPS, Beats Revenue for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips EyePoint Pharmaceuticals (NASDAQ:EYPT) just reported results for the first quar...

News Image11 days ago - EyePoint Pharmaceuticals, Inc.EyePoint Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Corporate Developments

– Company on track to initiate the Phase 3 LUGANO pivotal non-inferiority trial of DURAVYU™ in wet AMD in 2H 2024 – – $299 million of cash and investments...

News Image13 days ago - ChartmillHere are the top movers in Monday's session, showcasing the stocks with significant price changes.

Which stocks are moving on Monday?

News Image13 days ago - ChartmillTop movers in Monday's session

Intrigued by the market activity in the middle of the day on Monday? Uncover the key winners and losers of today's session in our insightful analysis.

News Image13 days ago - Market News VideoMonday Sector Laggards: Food, Drugs
News Image13 days ago - ChartmillGapping stocks in Monday's session

The market is buzzing with gapping stocks on Monday. Let's uncover which stocks are experiencing notable gaps during today's session.

News Image13 days ago - ChartmillTop movers in Monday's pre-market session

Wondering what's happening in Monday's pre-market session? Find an overview in this article.

News Image13 days ago - EyePoint Pharmaceuticals, Inc.EyePoint Pharmaceuticals Announces Topline Data from the Phase 2 PAVIA Trial of DURAVYU™ in Non-Proliferative Diabetic Retinopathy

– DURAVYU demonstrates stable or improved disease severity with reduced rates of NPDR progression at nine months – – DURAVYU continues to demonstrate...

News Image16 days ago - Market News VideoNoteworthy Friday Option Activity: IAC, BYON, EYPT
News Image24 days ago - Market News VideoEYPT Crosses Below Key Moving Average Level
EYPT Links
Follow us for more